全文获取类型
收费全文 | 2703篇 |
免费 | 266篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 108篇 |
妇产科学 | 71篇 |
基础医学 | 408篇 |
口腔科学 | 40篇 |
临床医学 | 360篇 |
内科学 | 476篇 |
皮肤病学 | 86篇 |
神经病学 | 134篇 |
特种医学 | 163篇 |
外科学 | 299篇 |
综合类 | 79篇 |
一般理论 | 1篇 |
预防医学 | 262篇 |
眼科学 | 110篇 |
药学 | 188篇 |
中国医学 | 3篇 |
肿瘤学 | 177篇 |
出版年
2021年 | 35篇 |
2020年 | 32篇 |
2019年 | 47篇 |
2018年 | 52篇 |
2017年 | 37篇 |
2016年 | 62篇 |
2015年 | 61篇 |
2014年 | 71篇 |
2013年 | 94篇 |
2012年 | 105篇 |
2011年 | 105篇 |
2010年 | 89篇 |
2009年 | 99篇 |
2008年 | 91篇 |
2007年 | 125篇 |
2006年 | 113篇 |
2005年 | 90篇 |
2004年 | 85篇 |
2003年 | 77篇 |
2002年 | 79篇 |
2001年 | 65篇 |
2000年 | 78篇 |
1999年 | 59篇 |
1998年 | 77篇 |
1997年 | 69篇 |
1996年 | 54篇 |
1995年 | 42篇 |
1994年 | 58篇 |
1993年 | 52篇 |
1992年 | 44篇 |
1991年 | 34篇 |
1990年 | 36篇 |
1989年 | 49篇 |
1988年 | 43篇 |
1987年 | 38篇 |
1986年 | 46篇 |
1985年 | 59篇 |
1984年 | 33篇 |
1983年 | 29篇 |
1982年 | 29篇 |
1981年 | 21篇 |
1980年 | 26篇 |
1979年 | 20篇 |
1978年 | 21篇 |
1977年 | 39篇 |
1976年 | 27篇 |
1975年 | 20篇 |
1974年 | 22篇 |
1971年 | 30篇 |
1970年 | 33篇 |
排序方式: 共有2986条查询结果,搜索用时 46 毫秒
81.
Brown G Hewitt E 《Proceedings of the National Academy of Sciences of the United States of America》1978,75(11):5268-5269
Singular continuous probability measures on the circle group are constructed whose Fourier-Stieltjes transforms converge to zero very rapidly and also have positive partial sums. Partial results for the line and for arbitary compact infinite Abelian groups are also obtained. 相似文献
82.
Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer 总被引:3,自引:3,他引:3
Onishi M; Mui AL; Morikawa Y; Cho L; Kinoshita S; Nolan GP; Gorman DM; Miyajima A; Kitamura T 《Blood》1996,88(4):1399-1406
Thrombopoietin and its receptor (MPL) are important regulators of megakaryopoiesis. We have identified an activating mutation of MPL using a combination of a retrovirus-mediated gene transfer and polymerase chain reaction-driven random mutagenesis. This point mutation causes a single amino acid substitution from Ser498 to Asn498 in the transmembrane region and abrogates factor-dependency of all interleukin-3-dependent cell lines tested. Murine interleukin-3- dependent Ba/F3 cells expressing the mutated but not the normal form of MPL were tumorigenic when transduced into syngeneic mice. Analysis of intracellular signaling pathways indicated that the mutant MPL protein constitutively activated two distinct signaling pathways, SHC-Raf-MAPK and JAK2-STAT3/STAT5. 相似文献
83.
The acylampicillins: mezlocillin, piperacillin, and azlocillin 总被引:7,自引:0,他引:7
The new acylampicillin derivatives azlocillin, mezlocillin, and piperacillin have an increased activity against many gram-negative bacilli, especially Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa, when compared with the carboxypenicillins carbenicillin and ticarcillin. The new penicillins show synergistic activity in combination with aminoglycosides but, when combined with other beta-lactams, may be synergistic (piperacillin and moxalactam; mezlocillin and cefoperazone), indifferent, or antagonistic (azlocillin, mezlocillin, or piperacillin and cefoxitin or cefamandole). The in vitro activity of these agents, either alone or in combination, appears to correlate with in vivo efficacy in animal models. The new penicillins are clinically effective for a very broad range of infections, including life-threatening nosocomial infections. Adverse effects with these, as with other semisynthetic penicillins, are minimal. Attention must be paid to the potential for infection by naturally resistant, gram-negative bacilli such as beta-lactamase-producing Escherichia coli and for the emergence of resistance during therapy. The granulocytopenic patient should receive these agents only in conjunction with another agent, such as an aminoglycoside; this combination will often result in a synergistic effect when tested in vitro. The carboxypenicillins and the newer penicillins have substantial similarities, and prospective, comparative studies have so far failed to demonstrate significant clinical superiority. However, the increased activity of the acylampicillins may be advantageous for the treatment of infections due to K. pneumoniae and P. aeruginosa. 相似文献
84.
NA Hanchard DR Murdock PL Magoulas M Bainbridge D Muzny YQ Wu M Wang AL McGuire JR Lupski RA Gibbs CW Brown 《Clinical genetics》2013,83(5):457-461
The advent of whole‐exome next‐generation sequencing (WES) has been pivotal for the molecular characterization of Mendelian disease; however, the clinical applicability of WES has remained relatively unexplored. We describe our exploration of WES as a diagnostic tool in a 3½‐year old female patient with a 2‐year history of episodic muscle weakness and paroxysmal dystonia who presented following a previous extensive but unrevealing diagnostic work‐up. WES was performed on the proband and her two parents. Parental exome data was used to filter potential de novo genomic events in the proband and suspected variants were confirmed using di‐deoxy sequencing. WES revealed a de novo non‐synonymous mutation in exon 21 of the calcium channel gene CACNA1S that has been previously reported in a single patient as a rare cause of atypical hypokalemic periodic paralysis. This was unexpected, as the proband's original differential diagnosis had included hypokalemic periodic paralysis, but clinical and laboratory features were equivocal, and standard clinical molecular testing for hypokalemic periodic paralysis and related disorders was negative. This report highlights the potential diagnostic utility of WES in clinical practice, with implications for the approach to similar diagnostic dilemmas in the future. 相似文献
85.
Janneke AL van Kempen Henk J Schers Anne Jacobs Sytse U Zuidema Franca Ruikes Sarah HM Robben René JF Melis Marcel GM Olde Rikkert 《The British journal of general practice》2013,63(608):e225-e231
Background
Primary care is increasingly interested in the identification of frailty, as it selects the target population for integrated care. However, instruments for the identification of frailty specifically validated for use in primary care are scarce. This study developed the Easycare Two-step Older persons Screening (Easycare-TOS), which provides a valid, efficient, and pragmatic screening procedure to identify frail older people.Aim
This paper aims to describe the development of the Easycare-TOS and the data from the pilot studies.Design and setting
Observational pilot study in seven academic GP practices in and around Nijmegen, The Netherlands.Method
The Easycare-TOS was developed in a cyclic process with the input of stakeholders. In every cycle, the requirements were first defined, then translated into a prototype that was tested in a pilot study. The Easycare-TOS makes optimal use of prior knowledge of the GP, and the professionals’ appraisal is decisive in the frailty decision, instead of a cut-off score. Further, it considers aspects of frailty, as well as aspects of the care context of the patient.Results
The pilot data have shown that after step 1, two-thirds of the patients do not need further assessment, because they are judged as not frail, based on prior knowledge of the GP. The overall prevalence of frailty in this pilot study is 24%. Most professionals who participated in the pilot studies considered the time investment acceptable and the method to be of added value.Conclusion
The Easycare-TOS instrument meets the predefined efficiency, flexibility, and acceptability requirements for use as an identification instrument for frailty in primary care. 相似文献86.
87.
Rebecca A. Ellwood Jennifer E. Hewitt Roberta Torregrossa Ashleigh M. Philp Justin P. Hardee Samantha Hughes David van de Klashorst Nima Gharahdaghi Taslim Anupom Luke Slade Colleen S. Deane Michael Cooke Timothy Etheridge Mathew Piasecki Adam Antebi Gordon S. Lynch Andrew Philp Siva A. Vanapalli Matthew Whiteman Nathaniel J. Szewczyk 《Proceedings of the National Academy of Sciences of the United States of America》2021,118(9)
88.
89.
90.
Elevated numbers of primitive Philadelphia chromosome-positive (Ph+) progenitors, including long-term culture-initiating cells (LTC-IC) as well as colony-forming cells (CFC), have been previously described in the blood of patients with chronic myeloid leukemia (CML) in chronic phase with high white blood cell counts. In the present study, which focused primarily on an analysis of circulating progenitors present in such patients at diagnosis, we discovered the frequent and occasionally exclusive presence of circulating normal (Ph-) LTC-IC, often at levels above those seen for LTC-IC in the blood of normal individuals. The presence of detectable numbers of circulating Ph- LTC-IC was independent of the fact that the same peripheral blood samples also contained elevated numbers of predominantly or exclusively Ph+ CFC. Interestingly, both the Ph+ and Ph- LTC-IC in these samples were CD34+CD71- and variably CD38- and Thy-1+, as previously documented for LTC-IC in normal marrow. Thus, neither CD38 nor Thy-1 expression was useful for discriminating between Ph+ and Ph- LTC-IC in mixed populations. Nevertheless, an association of these phenotypes with LTC- IC function did allow highly enriched (> 5% pure) suspensions of either Ph+ or Ph- LTC-IC to be obtained from selected samples of CML blood in which the initial LTC-IC population was either predominantly Ph+ or Ph- , respectively. These findings suggest that the mechanisms causing mobilization of leukemic stem cells in untreated CML patients may affect their normal counterparts. They also indicate a possible new source of autologous cells for the support of intensive therapy of CML patients. Finally, they provide a method for obtaining the most highly purified populations of Ph+ LTC-IC described to date. This method should be useful for further analyses of the molecular activities of these very primitive neoplastic cells. 相似文献